Dilaudid 8mg is a high-potency, immediate-release oral tablet formulation of hydromorphone hydrochloride, a potent Schedule II opioid agonist. It is prescribed strictly for the management of severe pain when alternative, non-opioid treatments are inadequate or tolerated poorly Because hydromorphone is a hydrogenated ketone of morphine, it is significantly more potent than morphine milligram-for-milligram. The 8mg tablet represents the highest immediate-release strength available and is generally reserved for patients who are already "opioid-tolerant Severe Risk of Overdose and Death: An 8mg dose can cause fatal respiratory depression (slowed or stopped breathing) if taken by someone who is not strictly opioid-tolerant Addiction, Abuse, and Misuse: Hydromorphone carries a very high risk of psychological and physical dependence. It must be taken exactly as directed, and the tablets must be swallowed whole—never crushed, chewed, or dissolved While standard initial dosing for immediate-release Dilaudid tablets typically starts at 2mg to 4mg every 4 to 6 hours as needed, an 8mg dose is typically reached through careful upward titration by a physician or as a calculated transition from another high-dose opioid regimen. If a patient has renal or hepatic impairment, starting doses must be drastically reduced Naloxone Availability: Due to the extreme potency of 8mg hydromorphone tablets, healthcare providers frequently advise keeping Naloxone (Narcan) nearby to reverse an accidental overdose